文献速递术前评估与围术期医学区域麻醉与超声疼痛医学

围术期麻醉管理与肿瘤进展:叙述性综述

Perioperative Anesthesia Care and Tumor Progression.
PubMed 文献 · Anesth Analg · 2017-01-01

本文为叙述性综述,聚焦围术期麻醉管理相关因素对肿瘤进展的影响,重点评价局麻药、区域麻醉结局研究、阿片类药物和NSAIDs对癌症手术患者复发的影响,并简要讨论挥发性与静脉麻醉药、围术期应激与焦虑、营养及免疫刺激等因素。近期系统综述关于区域麻醉与癌症复发关联的数据尚无定论,不足以证明区域麻醉的明确获益。

要点

  • 区域麻醉与癌症复发关联的系统综述数据尚无定论,证据不足以证明明确获益。
  • 基础科学提示局麻药具有抗肿瘤效应,新 refined 动物模型显示阿片类药物可安全用于围术期疼痛管理。
  • 初步证据提示NSAIDs应作为多模式镇痛的重要组成部分;挥发性麻醉药增加肿瘤形成,丙泊酚临床前及 emerging 临床数据提示肿瘤保护特性。

核心结论

  • 区域麻醉与癌症复发关联的近期系统综述数据尚无定论,证据不足以证明区域麻醉的明确获益。
  • 基础科学数据提示局麻药诱导抗肿瘤效应,新 refined 动物模型显示阿片类药物可安全用于围术期疼痛管理。
  • 初步证据提示NSAIDs应作为多模式镇痛的重要组成部分;挥发性麻醉药增加肿瘤形成,丙泊酚临床前及 emerging 临床数据提示肿瘤保护特性。

研究设计与样本

  • 叙述性综述,聚焦围术期麻醉管理 bundle 因素对肿瘤进展影响的最新 findings,批判性评价局麻药、区域麻醉结局研究、阿片类药物和NSAIDs相关文献。

主要发现

  • 区域麻醉与癌症复发关联的近期系统综述数据尚无定论,证据不足以证明区域麻醉的明确获益。
  • 基础科学数据提示局麻药诱导抗肿瘤效应;新 refined 动物模型显示阿片类药物可安全用于围术期疼痛管理。
  • 初步证据提示NSAIDs应作为多模式镇痛的重要组成部分;挥发性麻醉药增加肿瘤形成,丙泊酚临床前及 emerging 临床数据提示肿瘤保护特性。

临床怎么用

  • 区域麻醉技术在有指征时,应与包含NSAIDs、阿片类药物和局麻药的多模式镇痛联合,以预防疼痛和神经内分泌应激反应的病理生理效应,作为平衡麻醉的重要组成部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This narrative review discusses the most recent up-to-date findings focused on the currently available "best clinical practice" regarding perioperative anesthesia care bundle factors and their effect on tumor progression. The main objective is to critically appraise the current literature on local anesthetics, regional outcome studies, opioids, and nonsteroidal anti-inflammatory drugs (NSAIDs) and their ability to decrease recurrence in patients undergoing cancer surgery. A brief discussion of additional topical perioperative factors relevant to the anesthesiologist including volatile and intravenous anesthetics, perioperative stress and anxiety, nutrition, and immune stimulation is included. The results of several recently published systematic reviews looking at the association between cancer recurrences and regional anesthesia have yielded inconclusive data and provide insufficient evidence regarding a definitive benefit of regional anesthesia. Basic science data suggests an anti tumor effect induced by local anesthetics. New refined animal models show that opioids can safely be used for perioperative pain management. Preliminary evidence suggests that NSAIDs should be an essential part of multimodal analgesia. Volatile anesthetics have been shown to increase tumor formation, whereas preclinical and emerging clinical data from propofol indicate tumor protective qualities. The perioperative period in the cancer patient represents a unique environment where surgically mediated stress response leads to immune suppression. Regional anesthesia techniques when indicated in combination with multimodal analgesia that include NSAIDs, opioids, and local anesthetics to prevent the pathophysiologic effects of pain and neuroendocrine stress response should be viewed as an essential part of balanced anesthesia.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Sekandarzad MW, van Zundert AAJ, Lirk PB, et al. Perioperative Anesthesia Care and Tumor Progression. Anesth Analg. 2017. PMID: 27828796. doi:10.1213/ANE.0000000000001652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。